Health News

At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.


ADHD and Kids
Do you feel like your child might have ADHD? It's time to take a close look and get the facts straight.
ADHD Medications: What You Should Know
Treating attention-deficit hyperactivity disorder (ADHD) with medication? Here's all you need to know about the available treatment options.
Women Who Use ADHD Meds: A Growing Group
The number of women who take medication for attention deficit hyperactivity disorder (ADHD) has sharply increased in recent years, according to the Centers for Disease Control and Prevention (CDC).
ADHD Rx Goes Generic
The US Food and Drug Administration (FDA) has approved the generic version of Strattera, a medication used to treat attention deficit hyperactivity disorder (ADHD).
Pay Attention to Your Exercise Habits
Exercise may alleviate symptoms of attention deficit hyperactivity disorder (ADHD) in adults, a new study found.
Choosing the Right ADHD Treatment
Behavior therapy may be an underused form of treatment for children with attention deficit hyperactivity disorder (ADHD), according to the Centers for Disease Control and Prevention (CDC).
Adderall: The Troubling Trends
More young adults are experimenting with the prescription drug Adderall, which is commonly used to treat attention deficit hyperactivity disorder (ADHD), than ever before. And that could be a big problem.
A New Type of ADHD Rx
Lots of kids have trouble swallowing pills. And lots of kids have attention deficit hyperactivity disorder (ADHD). For kids who fall into both groups, there may be a new treatment option.
New ADHD Rx Gets FDA Nod
Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD), today announced that the U.S. Food and Drug Administration (FDA) approved Adzenys XR-ODT™ for the treatment of ADHD in patients six years and older. With this approval, Adzenys XR-ODT is the first and only extended-release orally disintegrating tablet (ODT) for the treatment of ADHD.
Chewable ADHD Rx Approved
Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved QuilliChew ER chewable tablets.